已收盘 08-01 16:00:00 美东时间
+0.160
+7.31%
Oppenheimer analyst Matthew Biegler initiates coverage on CytomX Therapeutics (NASDAQ:CTMX) with a Outperform rating and announces Price Target of $7.
07-31 20:04
CytomX Therapeutics will release its second quarter financial results on August 7, 2025, followed by a conference call and webcast at 5:00 p.m. ET / 2:00 p.m. PT. The webcast can be accessed via the company's website, and participants can register in advance. The company, focused on developing conditionally activated biologics for oncology, has a pipeline including ADCs, T-cell engagers, and cytokines, such as CX-2051 and CX-801. CytomX collabora...
07-31 12:00
NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the di...
07-09 20:30
CytomX Therapeutics, Inc. announced that CEO Sean McCarthy will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2025. The presentation will be available live on CytomX’s website, with management also offering one-on-one investor meetings. CytomX, a clinical-stage oncology-focused biopharmaceutical company, specializes in developing conditionally activated biologics that target the tumor microenvironment. It...
05-29 12:00
U.S. stocks were slightly lower, with the Dow Jones index falling around 0.1% o...
05-28 22:23
潜在涨幅300.0%!HC Wainwright & Co.:Armata Pharmaceuticals获机构升目标价至9美元,维持"买入"评级
05-21 16:44
Providing a diverse range of perspectives from bullish to bearish, 4 analysts h...
05-20 20:01
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities:维持Mersana Therapeutics(MRSN)"买入"评级,目标价从9美元升至10美元</p> <p>• Guggenheim:维持Cabaletta Bio(CABA)"买入
05-17 08:44
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按:每日追踪华尔街最新评级与目标价,挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim:维持Cabaletta Bio(CABA)"买入"评级,目标价从23美元升至25美元</p> <p>• 瑞穗:维持Tectonic Therapeutic(TECX)"跑赢大市"评级,目标价从51美元
05-16 08:43
Piper Sandler analyst Joseph Catanzaro maintains CytomX Therapeutics (NASDAQ:CTMX) with a Overweight and raises the price target from $2.5 to $5.
05-16 00:14